Lakewood-Amedex Biotherapeutics, Inc. (LABT)
NASDAQ: LABT · Real-Time Price · USD
0.2522
+0.0393 (18.46%)
Nov 20, 2026, 9:55 AM EST - Market open
LABT Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, LABT stock has an average price target of $7.50. The average 1-year stock price forecast is 2,873.83% higher than the current stock price, while the lowest is $3.00 (+1,089.53%) and the highest is $12 (+4,658.13%).
Price Target: $7.50 (+2,873.83%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for LABT is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 0 | 0 | 0 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $3 | Buy | Reiterates | $3 | +1,089.53% | Nov 17, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.96
from -8.40
EPS Next Year
-0.96
from -4.96